Luca Dozza

1.3k citations
24 papers · 894 · 1 hit paper · h-index 12

Impact in

Papers in

    • Multiple Myeloma Research and Treatments 13
    • Peptidase Inhibition and Analysis 5
    • Cancer Treatment and Pharmacology 3

Luca Dozza

23 papers receiving 863 citations

Luca Dozza's Hit Papers

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study 2020 · 295 citations
2950+2+4Years since publication50100150200250

Peers

Luca Dozza
Comparison fields: 5 of 50
  • Hematology 526
  • Cardiology and Cardiovascular Medicine 217
  • Oncology 245
  • Genetics 56
  • Molecular Biology 346
Replace Leanne M. McCulloch with:
Leanne M. McCulloch United States
Tommaso Caravita di Toritto Italy
Silvia G. R. Verelst Netherlands
Ana‐Maria Vlădăreanu Romania
Shin Matsuda Japan
Katerina Sfiridaki Greece
José Miguel Torregrosa Diaz France
Marco Santoro Italy
Özden Vural Türkiye
Cristina Gil Spain
Luca Dozza relative to Leanne M. McCulloch United States Leanne M. McCulloch's profile →
Citations per field
00.5×2×3×4×
Leanne M. McCulloch · 1×
Citations per year

Countries citing papers authored by Luca Dozza

Since Specialization
Citations

This map shows the geographic impact of Luca Dozza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Dozza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Dozza more than expected).

Fields of papers citing papers by Luca Dozza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Dozza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Dozza. The network helps show where Luca Dozza may publish in the future.

Co-authors

The 25 scholars most cited alongside Luca Dozza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Luca Dozza Line = papers co-authored together Luca Dozza links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Hit paper breakdown →
2020295
2 2014169
3 2020107
4 201946
5 202042
6
Autologous Stem Cell Transplantation Versus Bortezomib-Melphalan-Prednisone for Newly Diagnosed Multiple Myeloma: Second Interim Analysis of the Phase 3 EMN02/HO95 Study
201739
7 202028
8 202227
9
BRAVISSIMO: 12-month results from a large scale prospective trial.
201324
10 201424
11 201519
12 202017
13 202011
14
Right Anterior Mini-Thoracotomy: A 'New Gold Standard' for Aortic Valve Replacement?
20156
15 20156
16 20156
17 20236
18 20175
19 20225
20 20204

About Luca Dozza

Luca Dozza is a scholar working on Hematology, Oncology, Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery, having authored 24 papers that have together received 894 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (13 papers), Protein Degradation and Inhibitors (6 papers), Peptidase Inhibition and Analysis (5 papers), Cardiac and Coronary Surgery Techniques (3 papers), Cancer Treatment and Pharmacology (3 papers), Atrial Fibrillation Management and Outcomes (2 papers), HIV/AIDS drug development and treatment (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Hematology (526 citations), Cardiology and Cardiovascular Medicine (217 citations), Oncology (245 citations), Genetics (56 citations) and Molecular Biology (346 citations). Luca Dozza has collaborated with scholars based in Italy, Netherlands and United States. Frequent co-authors include Silvano Ferrari, Paolo Pillastrini, Marco Monticone, Carla Vanti, Mauro Del Giglio, Simone Calvi, Elisa Mikus, Simone Turci, Marina Martello and Carolina Terragna. Their work appears in journals such as Blood, The Lancet Haematology, Hematological Oncology, American Journal of Hematology and The Annals of Thoracic Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact